Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Stifel Analyst Increases Price Target for Ulta Beauty to 565

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Food Retailers Market Capitalization
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On March 15, 2024, analyst Mark Astrachan from Stifel continues to cover Ulta Beauty (NASDAQ: ULTA) with a Hold rating and increases the price target to $565 from $505.

This adjustment signifies Stifel’s evaluation of Ulta Beauty’s progress and opportunities within the market.

ULTA Beauty Inc. (ULTA) Stock Price Drops 6.52% on March 15, 2024: What Investors Need to Know

On March 15, 2024, ULTA Beauty Inc. (ULTA) experienced a significant drop in its stock price, with shares decreasing by $36.84, or 6.52%. The stock opened at $503.85, which was $61.59 lower than its previous close. This decline in price marks a notable shift in the stock’s performance.

Despite this drop, ULTA is still trading near the top of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been performing well overall in the longer term, but the recent price drop may be cause for concern among investors.

It’s important to consider the factors that may have contributed to this decline in ULTA’s stock price. Market conditions, company performance, and industry trends can all play a role in determining a stock’s performance on any given day. Investors should closely monitor these factors to gain a better understanding of why the stock price has dropped and what potential implications it may have for the future.

Overall, the drop in ULTA’s stock price on March 15, 2024, serves as a reminder of the volatility of the stock market and the importance of staying informed and proactive in managing investments. By staying vigilant and informed, investors can navigate market fluctuations and make sound investment decisions.

ULTA Beauty, Inc. Stock Performance Analysis: Stable Revenue but Decrease in Net Income and EPS

On March 15, 2024, ULTA Beauty, Inc. (ULTA) stock performance was relatively stable despite some fluctuations in key financial metrics. According to data from CNN Money, ULTA reported a total revenue of $11.21 billion over the past year, with $2.49 billion in the third quarter. This represents a 9.78% increase in total revenue since last year, but total revenue held flat since the last quarter.

In terms of net income, ULTA reported $1.29 billion over the past year and $249.48 million in the third quarter. This represents a 3.91% increase in net income since last year, but a significant decrease of 16.87% since the last quarter. Earnings per share (EPS) for ULTA were reported at $24.01 over the past year and $5.07 in the third quarter. This represents a 33.58% increase in EPS since last year, but a decrease of 15.82% since the last quarter.

Tags: ULTA
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_ stocks to buy

Analyst Reaffirms Outperform Rating and 6 Price Target for Geron NASDAQ GERN

Renewable energy

CBAK Energy Technology Reports Strong Revenue Growth in Q4 2023

Financing and finances

Analysis of Recent Analyst Ratings and Price Targets for APA

Recommended

Baidu Stock

Baidu’s Strategic Moves in Autonomous Driving and AI Draw Mixed Investor Reactions

1 month ago

Windtree Therapeutics Achieves Financial Stability and Advances Clinical Programs

2 years ago
Technology Data analytics Stock Bull Market

Anticipation High for Adobes FirstQuarter Financial Results and AI Innovation

2 years ago
Ideaya Biosciences Stock

Ideaya Biosciences: A Tale of Market Skepticism and Clinical Promise

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

AES Shares Surge on Potential $38 Billion Acquisition Speculation

Kura Oncology Investors Await Crucial FDA Verdict

Cadence Design Stock: A Battle Between Fundamentals and Market Signals

Trending

DuPont de Nemours Stock
Analysis

DuPont Faces Critical Test as Quarterly Results Loom

by Dieter Jaworski
November 6, 2025
0

DuPont de Nemours finds itself at a pivotal moment as the chemical giant prepares to release quarterly...

Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025
Emerson Electric Stock

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

November 6, 2025
Lanzatech Global Stock

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

November 6, 2025
Darden Restaurants Stock

Is Darden Restaurants Facing a Critical Test?

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DuPont Faces Critical Test as Quarterly Results Loom
  • Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure
  • Emerson Electric’s Strategic Pivot Faces Market Scrutiny

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com